- Home
- RDW vs CNTA Comparison
RDW vs CNTA Comparison
Compare RDW & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDW
- CNTA
- Stock Information
- Founded
- RDW 2020
- CNTA 2020
- Country
- RDW United States
- CNTA United Kingdom
- Employees
- RDW N/A
- CNTA N/A
- Industry
- RDW Military/Government/Technical
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- RDW Industrials
- CNTA Health Care
- Exchange
- RDW Nasdaq
- CNTA Nasdaq
- Market Cap
- RDW 2.0B
- CNTA 1.9B
- IPO Year
- RDW N/A
- CNTA 2021
- Fundamental
- Price
- RDW $9.09
- CNTA $17.64
- Analyst Decision
- RDW Strong Buy
- CNTA Strong Buy
- Analyst Count
- RDW 7
- CNTA 11
- Target Price
- RDW $17.50
- CNTA $28.90
- AVG Volume (30 Days)
- RDW 5.4M
- CNTA 1.1M
- Earning Date
- RDW 08-06-2025
- CNTA 08-12-2025
- Dividend Yield
- RDW N/A
- CNTA N/A
- EPS Growth
- RDW N/A
- CNTA N/A
- EPS
- RDW N/A
- CNTA N/A
- Revenue
- RDW $261,353,000.00
- CNTA $15,000,000.00
- Revenue This Year
- RDW $46.40
- CNTA N/A
- Revenue Next Year
- RDW $44.30
- CNTA N/A
- P/E Ratio
- RDW N/A
- CNTA N/A
- Revenue Growth
- RDW N/A
- CNTA 118.88
- 52 Week Low
- RDW $5.27
- CNTA $9.60
- 52 Week High
- RDW $26.66
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- RDW 29.32
- CNTA 65.83
- Support Level
- RDW $13.10
- CNTA $16.25
- Resistance Level
- RDW $9.77
- CNTA $17.37
- Average True Range (ATR)
- RDW 1.09
- CNTA 0.95
- MACD
- RDW -0.58
- CNTA -0.00
- Stochastic Oscillator
- RDW 5.60
- CNTA 94.87
About RDW Redwire Corporation
Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.